Abstract
We investigated whether metabolically healthy normal weight adults with central obesity
display worse cardiometabolic profile compared with their centrally lean counterparts.
This retrospective, cross-sectional study, comprised 1 135 subjects (64% females)
aged 18-to-81 years, presenting ≤2 components of metabolic syndrome. They were classified
as centrally lean (waist-to-height ratio (WHtR)<0.5 and waist circumference<80 cm
in females and<94 cm in males) or presenting central obesity (WHtR ≥0.5, regardless
of waist circumference). Data on blood pressure, glucose homeostasis, lipid profile,
renal function, high-sensitive C-reactive protein (hsCRP), uric acid, adiponectin,
leptin, and soluble receptor for advanced glycation end products were compared between
the groups, separately in males and females. 5.7% of males and 6.9% of females presented
WHtR ≥0.5. Compared with centrally lean subjects, those with central obesity had higher
BMI-adjusted fasting plasma glucose (p<0.001), and leptin levels (p<0.05); females
also presented higher blood pressure (p<0.001), while males had higher hsCRP concentrations
(p=0.021). These changes associated with significantly higher BMI-adjusted odds to
present fasting plasma glucose >5.6 mmol/l in both genders, higher odds to present
hsCRP >3 mg/l in males, and those to present elevated blood pressure in females. Our
analysis suggests that in metabolically healthy normal weight subjects WHtR ≥0.5 might
indicate “early increased health risk”.
Key words
waist-to-height ratio - fasting plasma glucose - blood pressure - hsCRP - leptin
